Wegovy Sales Strongly Increased Despite Generic Competition

Reading Time: 3 minutes
In the USA, pharmacies are producing more affordable generics of the medications Ozempic and Wegovy from Novo Nordisk. The pharmaceutical company Novo Nordisk (i) reports a strong increase in sales for its successful weight loss product Wegovy in the second quarter, even though many patients in the USA are turning to cheaper generic alternatives. The Danish company announced that sales of Wegovy have risen by 67% compared to the previous year. Challenges from generics Despite this success, Novo Nordisk warned that sales of its brand-name drugs...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.